Gefapixant does not have meaningful drug interactions with a MATE1/2K inhibitor or an OATP1B substrate
Year: 2020
Type: conference-abstract
Source: European Respiratory Journal
Language: English
Subfield: Pharmacology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W3096412596
